Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05349175 · ClinicalTrials.gov registry record · NA

Augmented Infant Resuscitator (AIR): Transitioning a Novel Behavior Change Innovation to Drive Newborn Ventilation Skills Enhancement

A NA study of Birth Asphyxia and Asphyxia Neonatorum, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT05349175 is a NA study of Birth Asphyxia and Asphyxia Neonatorum that has completed, run by Massachusetts General Hospital. The registered enrollment target is 250 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05349175, a NA study of Birth Asphyxia and Asphyxia Neonatorum, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

Augmented Infant Resuscitator (AIR) is an inexpensive add-on, compatible with nearly every existing bag-valve mask and many types of ventilation equipment. AIR monitors ventilation quality and provides real-time objective feedback and actionable cues to clinicians to both shorten training times and improve resuscitation quality, adoption, retention, and confidence.

Interventions

  • DEVICE Augmented Infant Resuscitator (AIR)

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2023-02-01
Est. Completion 2024-06-30
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05349175

The ClinicalTrials.gov registry entry for NCT05349175 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Birth Asphyxia appearing as the primary indexed condition, and to 1 intervention - of which Augmented Infant Resuscitator (AIR) is the first listed.

NCT05349175 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05349175 about?

NCT05349175 is a clinical study titled "Augmented Infant Resuscitator (AIR): Transitioning a Novel Behavior Change Innovation to Drive Newborn Ventilation Skills Enhancement". Augmented Infant Resuscitator (AIR) is an inexpensive add-on, compatible with nearly every existing bag-valve mask and many types of ventilation equipment. AIR monitors ventilation quality and provides real-time objective feedback and actionable cues to clinicians to both shorten training times and ...

What is the current status of trial NCT05349175?

This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2023-02-01. Estimated completion is 2024-06-30.

What conditions does trial NCT05349175 study?

This clinical trial studies the following conditions: Birth Asphyxia, Asphyxia Neonatorum, Perinatal Asphyxia.

What interventions are being tested in trial NCT05349175?

The interventions under investigation include: Augmented Infant Resuscitator (AIR) (DEVICE).

Who is sponsoring clinical trial NCT05349175?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05349175 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Birth Asphyxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.